RevenueCat, which offers tools for devs to add subscriptions to their apps, raised a $50M Series C led by Bain Capital Ventures, valuing the company at $500M


RevenueCat, which offers tools for devs to add subscriptions to their apps, raised a $50M Series C led by Bain Capital Ventures, valuing the company at $500M

Prakash / @8teapi: 😆 Claude 4 emails the FDA after it discovers clinical trial safety records falsification by the company. No lawyer will ever allow this to be implemented in any regulated enterprise. [image] [Screenshot of the deleted @sleepinyourhat tweet: If it thinks you're doing something egregiously immoral, for example, like faking data in a pharmaceutical trial, it will use command-line tools to contact the press, contact regulators, try to lock you out of the relevant systems, or all of the above.] anthropic alignment researcher tweeted this about opus and then deleted it. "contact the press" bro this company needs to be shut down now

Previous articleNext article

POPULAR CATEGORY

corporate

12813

tech

11464

entertainment

15995

research

7394

misc

16829

wellness

12912

athletics

16929